Nursing home diabetes care is its own clinical world. About 30 percent of long-term-care residents have diabetes, and many were on regimens designed for community-dwelling adults that no longer fit. Hypoglycemia — not hyperglycemia — is the dominant safety concern. Falls from hypoglycemia are a leading cause of preventable hospitalization. Sliding-scale insulin alone, long-acting sulfonylureas, and tight A1C targets that made sense at 60 often no longer make sense at 85. The American Diabetes Association, the American Geriatrics Society, and the American Medical Directors Association have converged on a framework that emphasizes permissive targets, structured deprescribing, and hypoglycemia avoidance.
Why Nursing Home Diabetes Is Different
- Higher rates of cognitive impairment, frailty, and polypharmacy.
- Variable food intake from meal to meal and day to day.
- Sleep, activity, and stress patterns that differ from community life.
- Reduced ability to recognize and report hypoglycemia symptoms.
- Staff turnover and variable diabetes-specific training.
- Multiple prescribers contributing to medication lists over time.
- Higher fall risk and worse outcomes when falls occur.
ADA Framework for Long-Term Care
| Resident Profile | A1C Target | Pre-Meal Glucose | Bedtime Glucose |
|---|---|---|---|
| Healthy, intact function | <7.5% | 90–130 | 90–150 |
| Multiple chronic conditions | <8.0% | 90–150 | 100–180 |
| Moderate frailty / dementia | <8.5% | 100–180 | 110–200 |
| End-stage / poor health | Avoid symptomatic hyperglycemia | 110–200 | 110–220 |
Medications to Avoid or Use Cautiously
- Glyburide: long-acting sulfonylurea — Beers Criteria recommends avoiding in older adults.
- Chlorpropamide: long-acting sulfonylurea — avoid.
- Sliding-scale insulin as sole regimen: Beers Criteria caution; produces wide glucose swings.
- Metformin with eGFR <30: contraindicated; reduce dose at eGFR 30–45.
- SGLT2 inhibitors: caution with volume depletion, UTIs, and DKA risk.
- Pioglitazone: edema, fracture risk, heart failure caution.
- High-dose insulin in frail residents: revisit total daily dose at each visit.
Reasonable Regimens for Long-Term Care
| Approach | When It Fits | Caveats |
|---|---|---|
| Lifestyle alone | Mild diabetes; A1C below target; very frail | Monitor for symptomatic hyper |
| Once-daily metformin | Stable kidney function; intact appetite | GI side effects; eGFR monitoring |
| Once-weekly GLP-1 RA | Caregiver-administered; CV benefit | Weight loss; nausea |
| Basal insulin once daily | Need for insulin; simple regimen | Hypoglycemia monitoring |
| Basal-plus (basal + 1 mealtime dose) | Insulin need with one large meal | Carb consistency at that meal |
| Basal-bolus structured | T1D or insulin-dependent T2D | Most staff training required |
Hypoglycemia Risk and Response
- Most severe hypoglycemia in nursing homes occurs at night or before breakfast.
- CGM can catch overnight lows that fingerstick checks miss — increasingly used in long-term care.
- All staff should have access to glucose tabs, gels, and IV dextrose orders.
- Nasal glucagon (Baqsimi) and prefilled glucagon pens (Gvoke) simplify staff administration.
- A documented hypoglycemia event should trigger regimen review within 48 hours.
- Pattern of recurrent hypoglycemia warrants reduction in insulin or discontinuation of sulfonylurea.
The “Treat to Deprescribe” Mindset
Many nursing home residents arrive on diabetes regimens designed years earlier. As function declines, total insulin requirements fall, kidney function changes, and the risk-benefit balance shifts. A structured deprescribing review — at admission, at any major health change, and at least annually — is now considered standard quality care. The goal is the simplest, safest regimen that prevents symptomatic hyperglycemia and DKA, not the tightest possible glucose control.
Staff Training Challenges
- High staff turnover means continuous re-training.
- Certified nursing assistants often deliver care without nurse-level diabetes training.
- Pump and CGM literacy varies widely — most homes are not equipped to manage AID systems.
- Standardized order sets reduce variability in insulin administration.
- Pharmacist consultation reduces medication-related adverse events.
- Manufacturer training (Lilly, Novo, Sanofi) is available free for many facilities.
Meal Timing and Carbohydrate Consistency
- Rigid meal-bolus timing is often unrealistic in long-term care — appetite is variable.
- Post-meal insulin dosing (after the resident eats) is safer than pre-meal dosing in residents with unpredictable intake.
- Carbohydrate-consistent meal plans simplify insulin dosing across many residents.
- Liberalized diets — fewer restrictions, more enjoyment — produce better outcomes than rigid diabetic diets in this population.
- Texture-modified diets for dysphagia need carbohydrate adjustment.
Family Advocacy
| Question to Ask | Why It Matters |
|---|---|
| What is my mother’s current A1C target? | Should be individualized, often 8–8.5% |
| Is she on sliding scale alone? | Discouraged by Beers Criteria |
| Has medication review been done? | Annual or per major change |
| Any hypoglycemia in last 90 days? | Triggers regimen review |
| Is glucagon available on the unit? | Emergency response capability |
| How often is glucose checked? | Less is often better in stable residents |
| Who is the medical director? | They set policy and respond to advocacy |
Role of the Medical Director and Consultant Pharmacist
The medical director sets facility-wide diabetes care policy and responds to family advocacy concerns. The consultant pharmacist reviews medication regimens monthly and is the natural ally for Beers Criteria-based deprescribing. AMDA (American Medical Directors Association) publishes long-term care diabetes guidance that aligns with ADA Section 13 and AGS Beers Criteria.
Insurance and Coverage
- Medicare covers skilled nursing facility stays for limited periods after qualifying hospitalization.
- Long-term custodial care is generally not covered by Medicare; Medicaid covers eligible residents.
- Long-term care insurance may cover residential care depending on policy.
- Veterans Affairs facilities have specific diabetes care protocols for eligible residents.
- CGM coverage in nursing homes is expanding under both Medicare and Medicaid.
Related Topics
Older adult diabetes physiology is covered in our type 1 diabetes in seniors over 70 and dementia and diabetes care guides. End-of-life decisions are covered in hospice and diabetes and end-of-life glycemic targets. Broader management context is in our treatment overview.
The Bottom Line
Nursing home diabetes care is a distinct clinical context. About 30 percent of residents have diabetes, and the priorities differ from community-dwelling adults. The American Diabetes Association supports A1C targets of 8 to 8.5 percent or higher in frail or complex residents — values below 7 percent are generally considered overtreatment. Sliding-scale insulin alone and long-acting sulfonylureas like glyburide are flagged by the American Geriatrics Society Beers Criteria. Hypoglycemia, not hyperglycemia, drives most preventable harm. Structured deprescribing, annual medication review, and family advocacy are the most effective levers for improving care. The role of the medical director and consultant pharmacist is central. Liberalized diets, post-meal insulin dosing when intake is variable, and CGM use are increasingly the standard of quality care. Families who ask specific questions about targets, medications, and hypoglycemia history get measurably better outcomes for their loved ones.
